» Articles » PMID: 7759783

Development of Hyperthyroidism in Nodular Goiter and Thyroid Malignancies in an Area of Relatively Low Iodine Intake

Overview
Publisher Springer
Specialty Endocrinology
Date 1995 Jan 1
PMID 7759783
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A high incidence of toxic nodular goiter has recently been described in areas of relatively low iodine intake. We studied the development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake (median 87 micrograms/h). The material comprised a total of 557 patients admitted to our department in the period 1978-88. The follow-up material consisted of 214 patients with a median age of 55 yr (19-86). Eighty-eight percent were females. The period of observation was 33 months (1-205). All patients had technetium thyroid scans, serum T3, serum T4, T3 uptake test and serum TSH performed. TRH tests were performed in 58 patients. During the follow-up period 45 initially euthyroid patients became hyperthyroid (18%). The incidence increased with age, and the median age in the group, who developed hyperthyroidism, was 65 yr. An estimated minimal incidence of toxic nodular goiter was 23/100,000/yr. Contrary to previous assumption, hyperthyroidism developed frequently in elderly patients with nodular goiter in a low iodine intake area. Thyroid cancer was found in 13 patients corresponding an estimated incidence of 1.5/100,000/yr. The cancer incidence was very low compared to other nordic countries with high iodine intake. This finding may suggest a possible influence of iodine intake on the incidence of thyroid cancer.

Citing Articles

Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.

Puzziello A, Carrano M, Angrisani E, Marotta V, Faggiano A, Zeppa P J Endocrinol Invest. 2014; 37(12):1181-6.

PMID: 25008459 DOI: 10.1007/s40618-014-0128-z.


Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).

Soriguer F, Santiago P, Vila L, ARENA J, Delgado E, Diaz Cadorniga F J Endocrinol Invest. 2009; 32(2):184-91.

PMID: 19411820 DOI: 10.1007/BF03345711.

References
1.
Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen I . Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab. 1987; 65(2):315-20. DOI: 10.1210/jcem-65-2-315. View

2.
STUDER H, Peter H, Gerber H . Toxic nodular goitre. Clin Endocrinol Metab. 1985; 14(2):351-72. DOI: 10.1016/s0300-595x(85)80038-4. View

3.
Laurberg P, Pedersen K, Vestergaard H, Sigurdsson G . High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland.... J Intern Med. 1991; 229(5):415-20. DOI: 10.1111/j.1365-2796.1991.tb00368.x. View

4.
Williams E, Doniach I, Bjarnason O, MICHIE W . Thyroid cancer in an iodide rich area: a histopathological study. Cancer. 1977; 39(1):215-22. DOI: 10.1002/1097-0142(197701)39:1<215::aid-cncr2820390134>3.0.co;2-#. View

5.
Kirkegaard C, Faber J, Friis T, Lauridsen U, Rogowski P . Intravenous and peroral TRH stimulation in sporadic atoxic goitre. Acta Endocrinol (Copenh). 1977; 85(3):508-14. DOI: 10.1530/acta.0.0850508. View